Beltran Pedro
SEC CIK 2058152 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Pres, CEO, Dir | 44.6K | — | — | 3 | 2026-03-10 | 2026-07-01 |
Most active insiders at BBOT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Elmelech Idan | COO, Principal Financial Ofcr | — | — |
| 2 | Beltran Pedro | Pres, CEO, Dir | — | — |
| 3 | Ben Yong | Chief Med, Dev Off | — | — |
| 4 | Mehra Uneek | Former Off | — | — |
| 5 | Cobo Marc | Principal Accounting Off | — | — |
| 6 | BridgeBio Pharma, Inc. | 10% | — | — |
| 7 | Chen Bihua | Dir, 10% | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 18:00 | 2026-07-01 | BBOT | BridgeBio Oncology Therapeutics, Inc. | Beltran Pedro | Pres, CEO, Dir | F - Tax | $7.80 | -1,047 | 44.6K | -2% | -$8,167 | |
| 2026-05-05 19:03 | 2026-04-01 | BBOT | BridgeBio Oncology Therapeutics, Inc. | Beltran Pedro | Pres, CEO, Dir | F - Tax | $9.03 | -1,047 | 45.6K | -2% | -$9,454 | |
| D | 2026-03-12 | 2026-03-10 | BBOT | BridgeBio Oncology Therapeutics, Inc. | Beltran Pedro | CSO | A - Grant | $0.00 | +46.7K | 46.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations